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ABSTRACT
Humans are exposed to N-nitroso compounds from
both endogenous and exogenous sources. Many
N-nitroso compounds can be metabolically activ-
ated to give diazoacetate, which can result in the
carboxymethylation of DNA. The remarkable similar-
ity in p53 mutations found in human gastrointestinal
tumors and in shuttle vector studies, where the
human p53 gene-containing vector was treated
with diazoacetate and propagated in yeast cells,
suggests that diazoacetate might be an important
etiological agent for human gastrointestinal
tumors. The O
6-carboxymethyl-2’-deoxyguanosine
was previously detected in isolated DNA upon expo-
sure to diazoacetate and in blood samples of
healthy human subjects. The corresponding modifi-
cations of thymidine and 2’-deoxyadenosine
have not been assessed, though significant muta-
tions at A:T base pairs were found in the p53
tumor suppressor gene in human gastrointestinal
tumors and in shuttle vector studies. To under-
stand the implications of the carboxymethyl-
ation chemistry of thymidine in the observed
mutations at A:T base pairs, here we synthesized
authentic N3-carboxymethylthymidine (N3-CMdT)
and O
4-carboxymethylthymidine (O
4-CMdT), incor-
porated them into DNA, and demonstrated, for the
first time, that they were the major carboxymethyl-
ated derivatives of thymidine formed in calf thymus
DNA upon exposure to diazoacetate. The demon-
stration of the formation of N3-CMdT and
O
4-CMdT in isolated DNA upon treatment with dia-
zoacetate, together with the preparation of authen-
tic oligodeoxyribonucleotide substrates housing
these two lesions, laid the foundation for investigat-
ing the replication and repair of these lesions and
for understanding their implications in the mutations
observed in human gastrointestinal tumors.
INTRODUCTION
Humans are exposed to N-nitroso compounds (NOCs)
from diet, tobacco smoke and other environmental
sources as well as from endogenous sources, and it was
estimated that the endogenous sources account for
45–75% of the total NOC exposure (1). The exposure to
endogenous NOCs was found to be signiﬁcantly asso-
ciated with the risk of developing non-cardia gastric
cancer in a recent large-scale epidemiological study, i.e.
European Prospective Investigation into Cancer and
Nutrition (EPIC) (2). This study included more than
half a million individuals and 314 incident cases of gastric
cancer that had occurred after an average of 6.6 years of
follow up (2).
Some endogenously produced NOCs are known to
cause damage to DNA and they are both mutagenic and
carcinogenic. Earlier studies by Wogan et al. (3) revealed
that the treatment of male Fischer rats with nitrosated bile
acid conjugates N-nitrosoglycocholic acid (NOGC) and
N-nitrosotaurocholic acid (NOTC) could induce signiﬁ-
cant levels of hepatocarcinoma in 54–70% of the treated
animals, and 12–13% of the treated rats developed
gastric tumors. Forward mutation assay in Salmonella
typhimurium and in TK6 diploid human lymphoblasts
showed that NOGC and NOTC are both mutagenic,
with NOGC being more eﬀective than NOTC in inducing
mutations in TK6 cells (4). In this regard, NOGC
could arise from the nitrosation of glycocholic acid
under simulated gastric conditions (5). Shuker et al. (6)
later demonstrated that the treatment of calf
thymus DNA with NOGC can induce the formation of
O
6-carboxymethyl-20-deoxyguanosine (O
6-CMdG) and,
to a much lesser extent, O
6-methyl-20-deoxyguanosine
(O
6-MdG, Scheme 1). By using immunoslot blot
assay or immunoaﬃnity/HPLC method with antibody
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6-carboxymethylguanine, Shuker et al.
(7–9) showed that O
6-CMdG can be induced in
DNA by N-nitroso glycine (NG, Scheme 1). In addition,
O-diazoacetyl-L-serine (also known as azaserine, AS,
Scheme 1), a pancreatic carcinogen (10), could induce
the carboxymethylation of guanine residues in DNA in
pancreatic acinar cells (11).
The above carboxymethylation was thought to
proceed through a common reactive intermediate,
diazoacetate (DA, Scheme 1), and it was demonstrated
that potassium diazoacetate (KDA) can induce the
formation of O
6-CMdG and, to a lesser degree (about
one-sixteenth of that of O
6-CMdG), O
6-methyl-20-
deoxyguanosine in DNA (7–9). Furthermore, it was
observed that humans consuming red meat have a
higher level of nitrosated compounds in feces (12) and
an elevated level of O
6-CMdG in colonic exfoliated
cells than control group consuming vegetarian diet (13).
O
6-CMdG was also detected at a level of three to eight
lesions per 10
7 nucleosides in the blood DNA of healthy
human subjects (9).
Some initial replication and repair studies have
been carried out for O
6-CMdG. In this context, it was
found that the azaserine-mediated cell killing cannot be
rescued by the overexpression of O
6-methylguanine
methyltransferase (MGMT) (14), which is keeping with
the observation that O
6-CMdG is not subjected to repair
by MGMT in vitro (6). On the other hand, lymphoblastoid
cells with deﬁciency in nucleotide excision repair (NER)
were signiﬁcantly more sensitive to azaserine than the con-
trol repair-proﬁcient cells, suggesting that O
6-CMdG can
be repaired by NER factors (14).
A very recent study by Gottschalg et al. (15) revealed
that the passage of KDA-treated, human p53 gene-
containing plasmid in yeast cells could result in substantial
single-base substitutions. Interestingly, KDA induced
almost equal distributions of transition and transversion
mutations, which diﬀers markedly from the predominant
GC!AT transition mutation (>80%) induced by methy-
lating agent methylnitrosourea (15), suggesting that DNA
methylation is not the major contributor to KDA-induced
mutations. Moreover, the identities and frequencies of
mutations induced by diazoacetate at non-CpG sites are
remarkably similar to the mutations at non-CpG sites in
p53 gene observed in human stomach and colorectal
tumors (15), suggesting that diazoacetate may constitute
an important etiological agent for the development of gas-
trointestinal cancer.
Gottschalg et al. (15) also observed a substantial fre-
quency of single-base substitutions at A:T base pairs in
p53 gene from shuttle vector studies and in human gastro-
intestinal tumors. For instance, the percentages of muta-
tions at A:T base pairs account for 43% and 28% of all
the observed mutations while the vector was treated with
KDA in PBS and Tris–EDTA, respectively (15). The
observation of a signiﬁcant proportion of mutations at
A:T base pairs supports that KDA can also induce pro-
mutagenic lesions at adenine and/or thymine. Although
KDA has been shown to induce the formation of
O
6-CMdG, it remains unexplored what types of lesions
can be induced at adenine and thymine sites in DNA by
KDA and what the mutagenic properties are for the
lesions induced at these two nucleobases.
As a ﬁrst step toward answering these questions, we
report here the chemical syntheses of N3- and O
4-carboxy-
methylthymidine, their incorporation into oligodeoxyribo-
nucleotides (ODNs), and the demonstration of their
formation in calf thymus DNA upon treatment with
diazoacetate.
MATERIALS AND METHODS
Materials
All chemicals, unless otherwise speciﬁed, were from
Sigma-Aldrich (St. Louis, MO). Common reagents for
solid-phase DNA synthesis were obtained from Glen
Research Co. (Sterling, VA).
Synthesis of standardN3-carboxymethylthymidine
(N3-CMdT, 1b, Scheme 2a)
In a ﬂask, 242mg of thymidine and 166mg of potassium
carbonate were dissolved in 50ml of anhydrous methanol.
To the solution was subsequently added 184mg of methyl
bromoacetate. The resulting solution was reﬂuxed for 6h.
Evaporation of solvent under reduced pressure aﬀorded
white solid which was then puriﬁed by silica gel column
chromatography with EtOAc/MeOH (85/15, v/v) as
mobile phase to give 152mg of 1a as colorless viscous
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of aqueous NaOH solution (0.5M) rendered 1b in sodium
salt form (119mg; yield 84%).
1a.
1H NMR (300MHz, CDCl3,2 5 8C, Figure S1): d
7.49 (s, 1H, H-6), 6.20 (t, 1H, H-10, J=6.6Hz), 4.69 (s,
2H, N3-CH2), 4.54 (m, 1H, H-30), 3.98 (m, 1H, H-40),
3.83–3.80 (m, 2H, H-50 and H-500), 3.75 (s, 3H, 3-OCH3),
2.35 (m, 2H, H-20 and H-200), 1.94 (s, 3H, 5-CH3).
HRMS (ESI): [M+H]
+ calcd m/z 315.1192, found
315.1184.
1b.
1H NMR (300MHz, D2O, 258C, Figure S2):
d 7.72 (s, 1H, H-6), 6.34 (t, 1H, H-10, J=6.6Hz), 4.50
(m, 3H, N3-CH2 and H-30), 4.07 (m, 1H, H-40), 3.93–3.79
(m, 2H, H-50 and H-500), 2.41–2.45 (m, 2H, H-20 and H-200),
1.96 (s, 3H, 5-CH3).
HRMS (ESI): [M+H]
+ calcd m/z 301.1025, found
301.1028.
Synthesis of O
4-carboxymethylthymidine (O
4-CMdT, 2d,
Scheme 1b)
Compound 2a was prepared following the previously pub-
lished procedures (16). Compound 1,2,4-triazole (414mg)
was suspended in anhydrous acetonitrile (9.0ml) in an ice
bath, and then POCl3 (110ml) was slowly added with rapid
stirring followed by dropwise addition of TEA (840ml).
Compound 2a (261mg) in  2.0ml acetonitrile was
subsequently added, and the solution was continuously
stirred for 90min. The reaction was terminated by
adding saturated NaHCO3 solution and extracted with
CH2Cl2. The organic layer was washed sequentially with
saturated NaHCO3 and brine, dried with Na2SO4, and the
solvent was evaporated under reduced pressure.
Puriﬁcation with silica gel column chromatography
using ethyl ether as mobile phase rendered 2b as white
solid (154mg; yield 63%).
Compound 2b (450mg) was dissolved in anhydrous
acetonitrile (8.0ml), and to this solution were added
methyl glycolate (240ml) and DBU (60ml). The resulting
solution was stirred at room temperature overnight and
subsequently acidiﬁed by adding an equal volume of 3%
trichloroacetic acid (TCA) in CH2Cl2. The solvent was
removed under reduced pressure, and the resulting resi-
dues were subjected to puriﬁcation with silica gel column
chromatography by using EtOAc/MeOH (85/15, v/v) as
the mobile phase. Compound 2c (182mg) was obtained as
colorless viscous liquid (yield 58%). Hydrolysis of 2c
(150mg) with 2.0ml of 0.1M aqueous NaOH solution
rendered 2d in sodium salt form (142mg; yield 92%).
2b.
1H NMR (300MHz, DMSO-d6,2 5 8C, Figure S3): d
9.35 (s, 1H, triazolyl H), 8.35 (s, 1H, triazolyl H), 8.27 (s,
1H, H-6), 6.80–7.32 (m, 26H, aromatic H of DMTr), 6.22
(t, 1H, H-10, J=6.2Hz), 4.09 (m, 1H, H-30), 3.82 (m, 1H,
H-40), 3.71 (m, 12H, OCH3 of DMTr), 3.23–3.04 (m, 2H,
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2.04 (s, 3H, 5-CH3).
HRMS (ESI): [M+Na]
+ calcd m/z 920.3635, found
920.3606.
2c.
1H NMR (300MHz, D2O, 258C, Figure S4): d 7.78
(s, 1H, H-6), 6.32 (t, 1H, H-10, J=6.0Hz), 4.78 (s, 2H,
O
4-CH2), 4.51 (m, 1H, H-30), 3.91 (m, 1H, H-40), 3.87 (m,
2H, H-50 and H-500), 3.82 (s, 3H, O
4-OCH3), 2.41 (m, 2H,
H-20 and H-200), 1.96 (s, 3H, 5-CH3).
HRMS (ESI): [M+H]
+ calcd m/z 315.1192, found
315.1186.
2d.
1H NMR (300MHz, D2O, 258C, Figure S5): d 7.71
(s, 1H, H-6), 6.34 (t, 1H, H-10, J=6.0Hz), 4.48 (m, 3H,
O
4-CH2 and H-30), 4.06 (m, 1H, H-40), 3.87 (m, 2H, H-50
and H-500), 2.43 (m, 2H, H-20 and H-200), 1.96 (s, 3H,
5-CH3).
HRMS (ESI): [M+H]
+ calcd m/z 301.1035, found
301.1034.
Synthesis of5’-O-(4,4’-dimethoxytrityl)-
N3-methoxycarbonylmethylthymidine (3a, Scheme 3)
Compound 3a was prepared from 1a following standard
procedures (17). Brieﬂy, 450mg of compound 1a was dis-
solved in anhydrous pyridine (10ml) and the solution was
cooled in an ice-bath. 4-Dimethylaminopyridine (DMAP,
10mg) and dimethoxytrityl chloride (DMTr-Cl, 340mg)
were added, and the resulting solution was stirred at
room temperature for 90min. The reaction was then
quenched with methanol (0.5ml), and the solvent was
removed under reduced pressure. The product was iso-
lated by silica gel column chromatography using 15%
MeOH in EtOAc as mobile phase, and dried under
reduced pressure to give a foam (565mg; yield: 64%).
3a.
1H NMR (300MHz, DMSO-d6,2 5 8C, Figure S6):
d 7.65 (s, 1H, H-6), 7.45–6.80 (m, 13H, aromatic H
of DMTr), 6.25 (t, 1H, H-10, J=6.3Hz), 5.38 (s, 1H,
30-OH), 4.58 (s, 2H, N3-CH2), 4.36 (m, 1H, H-30), 4.04
(m, 1H, H-40), 3.72 (s, 6H, OCH3 of DMTr), 3.67
(s, 3H, 3-OCH3), 3.23 (m, 2H, H-50 and H-500), 2.25
(m, 2H, H-20 and H-200), 1.99 (s, 3H, 5-CH3).
HRMS (ESI): [M+Na]
+ calcd m/z 639.2318, found
639.2300.
Synthesis of 5’-O-(4,4’-dimethoxytrityl)-
N3-methoxycarbonylmethylthymidine-3’-O-
[(2-cyanoethyl)-N,N-diisopropylphosphoramidite] (3b)
To a ﬂask, which was suspended in an ice bath and con-
tained a solution of compound 3a (92.4mg) in dry CH2Cl2
(3.0ml), was added N,N-diisopropylethylamine (DIEA,
52ml) followed by dropwise addition of 2-cyanoethyl-
N,N-diisopropyl chlorophosphoramidite (60ml). The mix-
ture was stirred at room temperature for 30min under an
argon atmosphere. The reaction was quenched by cooling
the mixture in an ice bath followed by slow addition of
CH3OH (0.40ml). The solution was quickly extracted with
EtOAc (8.0ml). The organic layer was washed with satu-
rated NaHCO3 (4.0ml) and brine (4.0ml), and dried with
anhydrous Na2SO4. The solvent was evaporated in vacuo
to yield 3b in white foam that was used for ODN synthesis
(101mg; yield: 84%).
3b.
1H NMR (300MHz, DMSO-d6,2 5 8C, Figure S7):
d 7.70 (s, 0.5H, H-6, diastereomer 1), 7.65 (s, 0.5H, H-6,
diastereomer 2), 7.39–6.82 (m, 13H, aromatic H of
DMTr), 6.43 (m, 1H, H-10), 4.71 (s, 2H, N3-CH2), 4.64
(m, 1H, H-30), 4.15 (m, 1H, H-40), 3.80 (s, 6H, OCH3 of
DMTr), 3.76 (s, 3H, 3-OCH3), 3.56–3.34 (m, 5H, 2H from
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(m, 2H, OCH2), 2.39 (m, 2H, H-20 and H-200), 1.46
(s, 3H, 5-CH3), 1.15-1.04 (m, 12H, CH3 from isopropyl).
31P NMR: d 149.9, 149.8.
HRMS (ESI): [M+Na]
+ calcd m/z 839.3397, found
839.3379.
ODNsynthesis
ODNs (sequences shown in the text) were synthesized on a
Beckman Oligo 1000S DNA synthesizer (Fullerton, CA)
at 1mmol scale. The synthesized phosphoramidite build-
ing block was dissolved in anhydrous acetonitrile at a
concentration of 0.07M. Standard phosphoramidite
building blocks (Glen Research Inc., Sterling, VA) of
dA, dC, dG and dT were employed, and a standard
ODN assembly protocol was used without any
modiﬁcation.
Synthesis of the ODNs containing N3-CMdT (3d)
started with 3b as phosphoramidite building block,
after synthesis (Scheme 3), the ODNs containing
N3-methoxycarbonylmethylthymidine were cleaved from
the controlled-pore glass (CPG) support with 1.0M
NaOH (3.0ml) at room temperature for 2 days. Under
such conditions, the nucleobase protecting groups were
removedandtheesterwashydrolyzedtothecorresponding
carboxylic acid derivative to yield the ODN containing 3c.
An O
4-triazolyl derivative of standard dT phosphora-
midite building block was used for synthesis of the ODNs
containing O
4-CMdT (4c, Scheme 4). After the ODN
assembly, the CPG support bearing 4a was ﬁrst suspended
in anhydrous acetonitrile (3.0ml). To the solution were
then added 50 equivalents of methyl glycolate and 15
equivalents of DBU, and the suspension was stirred at
room temperature for 24h, which oﬀered the CPG sup-
port bearing 4b. The solvent was removed by ﬁltration.
The 4b-containing ODN was hydrolyzed with 0.1M
NaOH (3.0ml) at room temperature for 3 days to aﬀord
4c, and in the mean time 4c was cleaved from the CPG
support and deprotected. The beads were then removed,
and the solution was neutralized with 0.1M HCl to pH 7.0
and lyophilized to dryness.
KDA treatment of calf thymus DNA
KDA was synthesized via alkaline hydrolysis of ethyl dia-
zoacetate (18). The concentration of KDA was estimated
by assuming that the hydrolysis reaction was quantitative.
Calf thymus DNA ( 1.0mg/ml) was treated with freshly
prepared KDA (8 or 20mM) in PBS buﬀer (pH 7.3) at
378C for 8h. The resulting DNA was isolated by ethanol
precipitation, and the recovered pellets were taken up into
doubly distilled water.
Enzymatic digestion of KDA-treated calf thymus DNA
One unit of nuclease P1, 0.01 unit of calf spleen phospho-
diesterase, and 2.5ml of buﬀer solution, which contained
sodium acetate (300mM, pH 5.0) and zinc acetate
(10mM), were added to a 20ml solution of KDA-treated
calf thymus DNA. The digestion was continued at 378C
for 6h. To the digestion mixture were then added 10 units
of alkaline phosphatase, 0.05 unit of snake venom phos-
phodiesterase, and 5 ml of 0.5M Tris–HCl (pH 8.9). The
digestion was continued at 378C for 6h, and the enzymes
were removed by chloroform extraction. The resulting
aqueous solution was lyophilized to dryness and redis-
solved in ultra-pure water for LC/MS analysis.
Mass spectrometry (MS)and NMR
Electrospray ionization-MS (ESI-MS) and tandem MS
(MS/MS) experiments were carried out on an LCQ Deca
XP ion-trap mass spectrometer (Thermo Fisher Scientiﬁc,
San Jose, CA). A mixture of acetonitrile and water (50:50,
v/v) was used as solvent for electrospray. The spray vol-
tage was 3.0kV, and the temperature of the heated capil-
lary was maintained at 2758C. High-resolution mass
spectra (HRMS) were acquired on an Agilent 6510
Q-TOF LC/MS instrument (Agilent Technologies, Palo
Alto, CA) equipped with an electrospray ionization
(ESI) source.
1H NMR spectra were recorded at
300MHz on a Varian Inova 300 NMR spectrometer
(Varian Inc., Palo Alto, CA), and
31P NMR spectra
were acquired at 80MHz on the same instrument.
2D NMR spectra were recorded in D2O using a Varian
Unity (Varian, Inc., Palo Alto, CA) spectrometer operat-
ing at 500MHz at 258C. A triple resonance 5mm
1H
13C
15N probe was used. Resonance assignments were
made based on
1H–
1H COSY and
1H–
13C HMBC experi-
ments. The HMBC spectra were acquired using sweep
widths of 5006.3Hz and 30177.3Hz for
1H and
13C,
respectively. The ﬁrst delay was set to match a 140Hz
coupling constant, and the second delay was set to
match a long-range coupling constant of 8Hz.
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Coupled liquid chromatography and ESI tandem MS
experiments were performed on an Agilent 1100 capillary
HPLC pump (Agilent Technologies) and an LTQ linear
ion trap mass spectrometer (Thermo Fisher Scientiﬁc, San
Jose, CA). A 0.5 150mm Zorbax SB-C18 column (5mm
in particle size, Agilent Technologies) was used, and a
0.1% formic acid in water (Solution A) and a 0.1%
formic acid in methanol (Solution B) were employed as
mobile phases. The ESI spray voltage was 3.0kV, and the
temperature of the heated capillary was maintained at
2758C.
HPLC purification
The puriﬁcation of ODNs was performed on a Beckman
HPLC System (32Karat software version 3.0, pump
module 125) with a UV detector (module 126) monitoring
at 260nm. A 4.6 250mm Apollo C18 column (5mmi n
particle size and 300A ˚ in pore size, Alltech Associate Inc.,
Deerﬁeld, IL) was used, and a 50mM triethylammonium
acetate buﬀer (TEAA, pH 6.6, Solution A) and a mixture
of 50mM TEAA and acetonitrile (70/30, v/v, Solution B)
were employed as mobile phases.
RESULTS
Chemical synthesis ofN3-and O
4-carboxymethylthymidine
To understand the implications of carboxymethylation
of thymidine in the diazoacetate-induced mutations
observed at A:T base pairs in human p53 tumor suppres-
sor gene, we set out to assess the carboxyalkylation chem-
istry of thymidine. To this end, we ﬁrst synthesized the
authentic N3- and O
4-carboxymethylthymidine (N3- and
O
4-CMdT).
We introduced the methyl ester derivative of the carbox-
ymethyl functionality to the N3 position of thymidine by
alkylation with methyl bromoacetate, and treated the
resulting compound with 0.5M NaOH to give the desired
N3-CMdT (Scheme 2a).
The chemical synthesis of O
4-CMdT was inspired by the
previous synthesis of ODNs bearing an O
4-methylthymi-
dine (19) and O
6-CMdG (20) (Scheme 2b). We incorpo-
rated the 1,2,4-triazolyl moiety to the C4 carbon atom of
30,50-O-di-DMTr-protected thymidine, which, upon treat-
ment with methyl glycolate in the presence of DBU,
renders the corresponding methyl ester of the di-DMTr-
protected O
4-CMdT. The DMTr groups in the latter deri-
vative were removed by using 3% TCA in CH2Cl2
(Scheme 2b, details shown in Materials and methods sec-
tion), and the resulting product was incubated with 0.1M
NaOH to give the corresponding carboxylic acid deriva-
tive (Scheme 2).
The structures of the two synthesized carboxymethy-
lated thymidine derivatives were supported by
1H NMR
and 2D heteronuclear multi-bond correlation (HMBC)
measurements. In particular, the two methylene protons
in the carboxymethyl functionality of N3-CMdT exhibit
strong correlation with the C2 and C4 of the thymine
ring in the 2D HMBC spectrum, whereas the two
corresponding methylene protons in O
4-CMdT show cor-
relation with the C4, but not the C2, of the thymine ring
(Figures S8 and S9). These distinct spectral features sup-
port the sites of carboxymethylation in these two thymi-
dine lesions.
Formation ofO
4-CMdT andN3-CMdT incalf thymus
DNA upon treatment with KDA
The availability of the standard O
4-CMdT and N3-CMdT
enabled us to assess whether these two lesions can be
induced in calf thymus DNA. To this end, we treated
calf thymus DNA with potassium diazoacetate, removed
the salts from the reaction mixture by ethanol preci-
pitation, digested the DNA with enzymes, and subjected
the resulting nucleoside mixture to LC-MS/MS
analysis, where we monitored selectively the fragmenta-
tion of the [M+H]
+ ion (m/z 301) of carboxymethylated
thymidines. The selected-ion chromatogram (SIC) for
monitoring the formation of the protonated carboxy-
methylthymine (i.e. m/z 185) revealed two peaks with elu-
tion time at 27.8 and 29.2min, respectively (Figure 1c).
The product-ion spectra averaged from these two peaks
showed the formation of a predominant fragment ion of
m/z 185 (insets in Figure 2c–d), which is attributed to form
from the elimination of a 2-deoxyribose component.
Further fragmentation of this ion (i.e. MS
3 experiment)
leads to the facile loss of a water molecule to give the
ion of m/z 167 (Figure 2c–d).
We also subjected standard O
4-CMdT and N3-CMdT
to LC-MS/MS analysis under the same experimental con-
ditions. It turned out that these two modiﬁed nucleosides
share the same retention times (Figure 1a–c) and the iden-
tical product-ion spectra (both MS/MS and MS
3,
Figure 2) as the two components present in the enzymatic
digestion mixture of KDA-treated calf thymus DNA.
Moreover, doping the nucleoside mixture arising from
the KDA-treated calf thymus DNA with N3-CMdT
leads to increase in signal for the ﬁrst peak (Figure 1d),
similar doping with O
4-CMdT results in a rise in signal
intensity for the later-eluting peak (Figure 1e), lending
further support that both O
4-CMdT and N3-CMdT
could be induced in calf thymus DNA upon KDA
treatment.
Incorporation of O
4-CMdT and N3-CMdT into ODNs
To understand the implications of O
4-CMdT and
N3-CMdT in the KDA-induced mutations observed
at T:A base pairs, it is important to obtain ODN
substrates housing a site-speciﬁcally inserted O
4-CMdT
and N3-CMdT for future replication and repair studies.
Therefore, we developed synthetic methods for the inser-
tion of these two lesions into ODNs at a unique site.
In this respect, the phosphoramidite building block of
the methyl ester derivative of N3-CMdT was prepared
from the above-described modiﬁed nucleoside following
standard procedures (Scheme 3) (17). After solid-phase
ODN assembly, we cleaved the ODN from the resin and
removed the nucleobase protecting groups by treatment
with 1.0M NaOH, which also converted the methyl
ester derivative to the corresponding carboxylic acid (20).
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above for the synthesis of O
4-CMdT was employed for
the synthesis of ODNs housing a site-speciﬁcally inserted
O
4-CMdT (Scheme 4). The 1,2,4-triazolyl-protected thy-
midine was incorporated into ODNs by using standard
phosphoramidite chemistry, and the triazolyl functionality
on thymidine was displaced with methyl glycolate while
the ODN was still on the resin. The resin was subsequently
treated with 0.1M NaOH to convert the ester derivative to
the corresponding carboxylic acid; such treatment also
resulted in the cleavage of the ODN from the solid sup-
port and the removal of the nucleobase protecting groups
(Scheme 4).
It is worth noting that alkaline conditions were
employed for the above conversion from methyl ester to
the corresponding carboxylic acid and for the nucleobase
deprotection, it is important to assess the stability of the
lesion-carrying ODNs under these basic conditions. Our
LC-MS/MS analyses showed that while the dodecameric
ODN containing N3-CMdT is stable under the alkaline
conditions (1.0M NaOH for 24h), the corresponding
O
4-CMdT-bearing ODN is not very stable under strong
alkaline conditions. Thus, we treated the ODN-carrying
solid support with 0.1M NaOH for 36h to facilitate
the above ester-to-acid conversion and the nucleobase
deprotection. In this context, our LC-MS analysis
showed that approximately 13% of the ODN has lost
the carboxymethyl group to produce the corresponding
unmodiﬁed thymidine-containing ODN. The thymidine
and O
4-CMdT-bearing ODNs, however, can be resolved
by HPLC.
The ODNs obtained from the above-described proce-
dures were characterized by ESI-MS and MS/MS to
conﬁrm their sequence and the location of carboxy-
methylation. Taking the characterizations of the d(ATG
GCGXGCTAT) (where ‘X’ represents O
4-CMdT) as an
example, we found that the measured m/z values for the
multiply deprotonated ions are consistent with their cal-
culated ones (Figure 3, inset). In addition, MS/MS of the
[M – 3H]
3– ion (m/z 1243.9, Figure 3) gives a series of
sequence ions, allowing us to establish unambiguously
that there is an O
4-CMdT at the seventh position in this
ODN counting from the 50 terminus. Upon collisional
activation in a mass spectrometer, an ODN undergoes
cleavages at the N-glycosidic bond and the 30 C–O bond
of the same nucleoside to form [an–Base] and its comple-
mentary wn ions, which carry the 50 and 30 termini of the
ODN, respectively (21). Because of the low proton aﬃnity
of thymine, the N-glycosidic bond in thymidine is usually
not susceptible to cleavage and, as a result, chain cleavage
is often not observed at the 30 C–O bond of this nucleoside
(22). In Figure 1, we observed [a3 – G], [a4 – G], [a5 – C],
[a6 – G], [a8 – G], [a9 – C], [a11 – A], w3,w 4,w 5,w 6,w 7,w 8,
w9 and w11 ions. The observed masses of w6,w 7,w 8,w 9
and w11 ions are 58 Da higher in masses than the calcu-
lated masses of the corresponding fragments for the
unmodiﬁed ODN, whereas the masses of the w3,w 4,w 5
ions are the same the calculated masses for the corres-
ponding fragments from the unmodiﬁed ODN, supporting
the presence of an O
4-CMdT at the seventh position of
this ODN. The same conclusion can be drawn based on
the observed masses of the [a – Base] series fragment ions.
Likewise, we characterized the synthesized N3-CMdT-
containing ODN by ESI-MS and MS/MS analyses
(spectra not shown).
DISCUSSION
Humans are exposed to NOCs from both endogenous and
exogenous sources (1), and a recent epidemiological
study found a signiﬁcant correlation between the human
exposure toward endogenous NOCs and the risk of
developing non-cardia gastric cancer (2). Endogenously
induced NOCs can be metabolically activated to give
diazoacetate, which can result in the alkylation of DNA
(1). An earlier study by Zurlo et al. (11) showed that the
exposure of pancreatic acinar cells to O-diazoacetyl-
L-serine, which can be metabolically activated to give
diazoacetate (Scheme 1), could induce the formation of
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Figure 1. LC-MS/MS for monitoring the formation of N3-CMdT and
O
4-CMdT in calf thymus DNA upon treatment with diazoacetate.
Shown are the SICs for monitoring the m/z 301!185 transition, corres-
ponding to the loss of a 2-deoxyribose, from the LC-MS/MS analyses
with the injection of: (a) N3-CMdT standard; (b) O
4-CMdT standard;
(c) enzymatic digestion mixture of calf thymus (ct) DNA treated with
20mM potassium diazoacetate (KDA, and the LC-MS/MS results from
the reaction with 8mM KDA are shown in Figure S7); (d) the sample
in (c) with the addition of standard N3-CMdT; and (e) the sample in
(c) with the addition of standard O
4-CMdT.
342 Nucleic Acids Research, 2009, Vol. 37, No. 27-carboxymethylguanine in DNA. It was also observed
that the treatment of calf thymus DNA with potassium
diazoacetate or NOCs could result in the formation of
O
6-CMdG (6–9). In addition, O
6-CMdG was detected at
a level of three to eight lesions per 10
7 nucleosides in the
blood DNA of healthy human subjects (9), and humans
consuming red meat have elevated level of O
6-CMdG
in colonic exfoliated cells than control group
consuming vegetarian diet (13). Moreover, the propaga-
tion of diazoacetate-treated, human p53 gene-containing
shuttle vector in yeast cells gave similar mutation pattern
at non-CpG sites as that found in human stomach and
colon cancers (15). Together, these previous studies estab-
lished a strong link between human exposure to N-nitroso
compounds and the carboxymethylation of DNA and sug-
gested that the exposure to N-nitroso compounds may
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Figure 2. Tandem mass spectra supporting the formation of N3-CMdT and O
4-CMdT in calf thymus DNA. Shown are the MS
3 results, which
monitors the further fragmentation of the protonated carboxymethylthymine (m/z 185), for: (a) standard N3-CMdT; (b) standard O
4-CMdT; (c) the
27.8min fraction shown in Figure 1c; and (d) the 29.2min fraction shown in Figure 1c. Depicted in the insets are the corresponding MS/MS for the
[M+H]
+ ions of the modiﬁed nucleosides. The ion of m/z 185 found in MS/MS is attributed the elimination of a 2-deoxyribose.
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development.
Aside from the above two dG adducts, the diazoacetate-
mediated carboxymethylation chemistry of other nucleo-
sides in DNA has not been assessed. Shuttle vector studies
revealed that diazoacetate treatment can also lead to sig-
niﬁcant mutations at T:A base pairs (15), suggesting that
diazoacetate can also lead to the modiﬁcation of thymine
and/or adenine in DNA. Here, we synthesized authentic
N3-CMdT and O
4-CMdT, and demonstrated, by using
LC-MS/MS, that indeed these two lesions could be
induced and they constitute the main thymidine products
formed in calf thymus DNA upon exposure to diazoace-
tate. The methods for the syntheses of N3-CMdT and
O
4-CMdT can be readily adapted for the preparation of
the corresponding stable isotope-labeled derivatives,
which facilitates the future LC-MS/MS quantiﬁcation of
these lesions formed in vitro and in vivo by using the iso-
tope dilution technique. In this context, it is worth
noting LC-MS/MS also revealed the carboxymethylation
of 20-deoxyadenosine in calf thymus DNA. The chemical
nature of the carboxymethylated adenine is currently
under investigation.
The formation of N3-CMdT and O
4-CMdT in calf
thymus DNA calls for the examination of the replication
and repair of these lesions. To carry out such studies, we
need to obtain ODN substrates housing a site-speciﬁcally
incorporated N3-CMdT and O
4-CMdT. Thus, we also
developed facile synthetic methods for the site-speciﬁc
incorporation of these two lesions into ODNs. In this
respect, the methods facilitated the preparation of
12-mer ODNs in reasonably good yield. After HPLC
separation and desalting, we were able to obtain
 100nmol of the lesion-bearing ODNs from a 1mmol
scale synthesis. Thus, the synthetic strategy facilitates the
availability of suﬃcient ODN substrates for future NMR
structural studies. The lesion-bearing substrates can also
be employed to construct, by enzymatic ligation, longer
lesion-bearing ODNs for in vitro DNA repair studies (23)
and damage-containing shuttle vectors for in vivo replica-
tion and repair studies (24,25).
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